Wet Granulator
Wet granulation in a high-shear mixer is a process where three simultaneous mechanisms — nucleation (binder-particle contact), coalescence (particle-particle agglomeration), and consolidation (intra-granule densification) — compete for dominance within a 3–8 minute window, and the final granule properties depend on which mechanism wins. The wet granulator's impeller speed, chopper configuration, and binder addition method are the three control levers that determine this outcome. Getting them wrong produces one of two failures: over-granulation (dense, oversized granules that fail dissolution) or under-granulation (friable, undersized granules that fail flow and compression). Getting them right — consistently, across batch sizes from 50 L to 600 L — requires understanding the granule growth regime map and engineering the equipment to operate within the target regime.
Related Products
The impeller is the primary energy input device in a high-shear wet granulator. Its blade geometry determines the powder flow pattern inside the bowl, which in turn determines how uniformly binder contacts the powder and how energy is distributed across the granulating mass.
Two impeller geometries dominate pharmaceutical wet granulation:
Bottom-driven vertical blade impeller. Mounted on a vertical shaft at the bowl bottom, with 2–3 blades angled at 30–45° from horizontal. This configuration creates a tumbling flow pattern — powder is lifted by the blade's leading edge, cascades down the bowl wall, and returns to the blade's path. The tumbling pattern provides good axial mixing (top-to-bottom) but moderate radial mixing (center-to-wall). The energy distribution is non-uniform: particles near the blade tip experience 3–5× higher shear than particles near the bowl center. This non-uniformity is acceptable for small bowls (below 100 L) but becomes problematic at production scale, where the energy gradient across a 400 L bowl can produce granules with 30–40% size variation between the bowl center and wall.
Side-driven horizontal blade impeller. Mounted on a horizontal shaft entering through the bowl sidewall, with 2–4 blades arranged in a paddle or plow-share configuration. This creates a centrifugal flow pattern — powder is thrown outward against the bowl wall, climbs the wall, and returns to the center along the bowl top. The centrifugal pattern provides more uniform radial energy distribution and is preferred for production-scale granulators (above 200 L) because the energy gradient between center and wall is reduced to approximately 1.5–2.0×.
At a Portuguese generic pharmaceutical facility, a formulation team producing 500 mg paracetamol granules transitioned from a 75 L bottom-driven granulator to a 300 L side-driven granulator during scale-up. The scale-up initially produced granules with d50 (median particle size) of 620 μm compared to 380 μm at the smaller scale — a 63% increase that pushed the granules out of the target range for the subsequent tableting step. The root cause was not the impeller speed (which had been scaled using tip-speed equivalence) but the chopper's ineffective action at the larger scale.
The chopper (also called the intensifier bar or disperser) is a high-speed blade mounted through the bowl sidewall or lid, typically rotating at 1,500–3,000 rpm. Its function is not to add energy to the granulating mass — that is the impeller's job. The chopper's role is to break apart oversized granule agglomerates as they form, preventing runaway granule growth.
The chopper's effectiveness depends on three parameters:
Blade tip speed — At 2,500 rpm with a 50 mm blade diameter, the tip speed is 6.5 m/s. This must exceed the granule coalescence velocity (the speed at which colliding granules merge rather than bounce apart). For most pharmaceutical formulations, tip speeds above 5 m/s effectively control oversized granule formation.
Immersion depth — The chopper blade must penetrate into the powder bed. If the fill level is too low, the chopper spins in air above the bed and has no effect. The chopper blade should be fully immersed when the bowl is filled to its operating volume.
Activation timing — The chopper should be activated during the binder addition phase (to break apart initial nuclei that are too large) and during the massing phase (to control continued growth). Running the chopper during dry mixing (before binder addition) can classification-segregate the powder blend by particle size.
In the Portuguese facility's scale-up case, the chopper on the 300 L granulator was positioned 120 mm above the bowl bottom — appropriate for the full 300 L fill volume but too high for the 180 kg batch (which filled only 60% of the bowl volume). The chopper blade was partially above the powder bed, reducing its effective cutting action. Lowering the chopper position by 40 mm and increasing chopper speed from 2,000 to 2,800 rpm brought the d50 down to 410 μm — within the target range of 350–450 μm.
The method of introducing binder into the powder bed profoundly affects nucleation — the first stage of granule formation where binder liquid contacts dry powder particles and creates initial nuclei. Three methods are used, each producing different nucleation regimes:
Pour addition. Binder is poured or pumped onto the powder surface without atomization. This produces large, saturated nuclei at the pour point — the binder does not distribute evenly across the powder bed. Pour addition is acceptable for formulations where granule size distribution is not critical (e.g., granulation prior to tableting with wide acceptable weight variation) but produces wide granule size distributions. The d10/d90 ratio (span) is typically 4–6.
Spray addition. Binder is atomized through a spray nozzle positioned above the powder bed. Droplet size (typically 50–200 μm) determines nucleation size — smaller droplets produce smaller, more uniform nuclei. Spray addition produces narrow granule size distributions (d10/d90 span of 2–3) and is the preferred method for GMP-validated pharmaceutical granulation. The critical spray parameter is the ratio of droplet size to powder particle size — if the droplet is more than 3× the particle size, the droplet engulfs multiple particles, creating oversized nuclei. If the droplet is smaller than the particle, the binder coats individual particles without forming bridges, and nucleation fails.
In-situ melt addition. A solid binder (e.g., polyethylene glycol, stearic acid) is blended with the powder and the granulator bowl is heated above the binder's melting point. The molten binder wets the powder from within, producing very uniform nucleation. This method eliminates the need for subsequent drying (the binder solidifies on cooling) but requires temperature-controlled granulator construction and limits the formulation to binders with melting points between 40–70°C.
A Czech pharmaceutical manufacturer — producing granules for a controlled-release metformin formulation — captured granule growth kinetics data across 12 production batches using in-line focused beam reflectance measurement (FBRM). The data below represents a typical batch with optimized impeller and chopper settings.
Span (d90-d10)/d50 | ||||||
0:00 | Dry mix start | 28 | 95 | 210 | 1.92 | 22 |
2:00 | Dry mix end | 30 | 98 | 215 | 1.89 | 24 |
2:30 | Binder spray start | 32 | 105 | 240 | 1.98 | 25 |
3:30 | Binder spray (50%) | 65 | 180 | 380 | 1.75 | 28 |
4:30 | Binder spray end | 120 | 280 | 520 | 1.43 | 31 |
5:30 | Massing (1 min) | 180 | 350 | 620 | 1.26 | 33 |
6:30 | Massing (2 min) | 220 | 395 | 680 | 1.16 | 34 |
7:00 | Endpoint | 235 | 410 | 700 | 1.13 | 35 |
7:30 | Over-massing (demonstrative) | 280 | 520 | 950 | 1.29 | 37 |
The data reveals the characteristic granule growth curve: slow nucleation during the first 30 seconds of binder addition, rapid coalescence between 1–3 minutes (d50 grows from 105 to 395 μm), and decelerating growth as the massing phase progresses. The critical observation is the span reduction from 1.98 to 1.13 — the granule size distribution narrows as growth progresses, indicating that the coalescence mechanism is self-limiting (larger granules have lower collision frequency and merge less readily). The over-massing row (7:30) shows the span widening again as consolidation produces dense, oversized granules — this is the over-granulation regime that must be avoided.
Bowl temperature rise from 22°C to 35°C during the 7-minute process is significant — it reflects the mechanical energy input and affects binder viscosity. For PVP (polyvinylpyrrolidone) binder solutions, viscosity decreases 15–20% between 22°C and 35°C, which changes the binder's distribution characteristics. Temperature monitoring is not optional — it is a critical process parameter that must be trended and controlled.
Determining when to stop the granulation process — the endpoint — is the most consequential decision in wet granulation. Stopping too early produces friable, low-density granules that fail compression. Stopping too late produces dense, oversized granules that fail dissolution. Three endpoint detection technologies are used in modern pharmaceutical granulation:
Impeller power consumption. The motor's power draw increases as the granulating mass transitions from dry powder (low power) to wet granules (high power, due to increased mass cohesion and viscosity). The power curve follows a characteristic S-shape: a gradual rise during nucleation, steep rise during coalescence, and plateau during consolidation. The endpoint is typically defined as the power level at the plateau onset — 85–90% of the plateau value. This method is inexpensive (the motor ammeter is already present) but is sensitive to batch size, fill level, and binder viscosity, requiring revalidation when these parameters change.
Torque measurement. Direct torque measurement on the impeller shaft provides a more accurate endpoint signal than motor power because it excludes motor efficiency and drivetrain losses. Torque sensors (strain gauge type) mounted on the shaft between the motor and the impeller provide real-time torque data. The torque curve mirrors the power curve but with higher signal-to-noise ratio and faster response time. Torque-based endpoint detection is the industry standard for GMP-validated high-shear granulation.
In-line FBRM or NIR. Focused beam reflectance measurement (FBRM) probes mounted through the bowl wall provide real-time particle size distribution data without sampling. Near-infrared (NIR) spectroscopy can monitor moisture content and granule density in real-time. These technologies provide the most granular process insight but cost $45,000–$120,000 per installation and require significant method development. They are justified for products with narrow therapeutic windows or complex controlled-release formulations where granule properties directly affect bioavailability.
Scale-up from lab to production is the most failure-prone step in wet granulation. The engineering challenge is that no single scaling rule preserves all three granulation mechanisms simultaneously. Common scaling rules include:
Tip speed equivalence — Maintain constant impeller tip speed (m/s) across scales. Preserves shear intensity at the particle level but does not account for the increased powder mass at larger scale, which absorbs more energy and slows nucleation.
Froude number equivalence — Maintain constant Froude number (Fr = ω²D/2g), which relates centrifugal force to gravitational force. Preserves the powder flow regime (tumbling vs. centrifugal) across scales. This is the most theoretically sound scaling rule for high-shear granulators.
Specific energy equivalence — Maintain constant energy input per kg of powder (kJ/kg). Preserves total mechanical work done on the powder but does not account for energy distribution differences between scales.
In practice, scale-up requires a combination of Froude number equivalence (for impeller speed) and empirical adjustment of chopper speed, binder addition rate, and massing time. Document the scale-up rationale in the process development report — GMP inspectors will ask for the scientific basis of scale-up parameters, and "we used the same settings" is not an acceptable answer.
Equipment cleaning is a major GMP concern for wet granulators because the wet mass adheres to bowl walls, blade surfaces, and chopper bearings. The granulator must be designed for CIP (clean-in-place) with spray balls positioned to reach all product contact surfaces, or for rapid disassembly for manual cleaning. Bottom-driven granulators with sealed bearings are more difficult to clean than top-driven granulators with the impeller shaft accessible from above. The chopper assembly is particularly challenging — the high-speed bearing housing can trap powder and binder residue, requiring complete disassembly for cleaning validation.
Inconsistent binder distribution with viscous binder solutions. Binder solutions above 15% concentration (e.g., 20% PVP K-30) have viscosities above 50 mPa·s that do not atomize well in standard spray nozzles. The result is intermittent large droplets that create localized over-wetted regions in the powder bed. The solution is either lower binder concentration (which increases the volume of liquid to add, extending the binder addition phase) or a high-pressure spray system with specialized nozzles (flat-fan or air-atomizing type) that can handle viscous liquids.
Bowl wall buildup during extended massing. Wet granulating mass adheres to the bowl wall, particularly at the wall-blade junction where flow is stagnant. This buildup changes the effective bowl volume and flow pattern, introducing variability between batches. Polished bowl surfaces (Ra ≤ 0.4 μm) reduce buildup, and PTFE-coated bowls eliminate it entirely — but PTFE coating wears and requires reapplication every 2–3 years.
Temperature rise affecting thermolabile APIs. The mechanical energy input during granulation raises the product temperature by 8–15°C. For thermolabile APIs (proteins, peptides, some antibiotics), this temperature rise can cause degradation. Jacketed granulator bowls with cooling water circulation can maintain product temperature within ±2°C of the setpoint, but this adds $15,000–$25,000 to the equipment cost.
Specify the granulator bowl volume based on the minimum and maximum batch sizes you intend to process. A bowl that is oversized for the batch (below 40% fill) produces poor mixing because the powder does not reach the impeller blade effectively. A bowl that is undersized (above 85% fill) restricts the tumbling flow and produces over-granulation. Ideally, the operating batch should fill 50–75% of the bowl volume. If your batch size range spans more than 3:1 (e.g., 50 kg to 200 kg), consider a granulator with interchangeable bowls of different volumes.
Verify that the impeller and chopper motors are sized for your formulation's worst-case energy demand. Dense mineral-based formulations at 80% fill can require 30–40% more torque than the same volume of light organic powder. If the motor is undersized, it will stall or trip during the high-torque massing phase — a catastrophic event that ruins the batch and requires complete bowl cleaning before restart.
Require the supplier to demonstrate the endpoint detection system during the FAT using a placebo formulation. The supplier should show the torque or power curve over a complete granulation cycle and explain the endpoint algorithm. If the supplier cannot demonstrate endpoint detection, the machine is not suitable for GMP production — endpoint determination is a regulatory expectation, not an optional feature.
For a 100 kg batch in a 250 L high-shear granulator: 2–3 minutes dry mixing, 2–4 minutes binder addition, 1–3 minutes massing — total 5–10 minutes. The total cycle time including charging, discharging, and cleaning is 25–45 minutes. The actual granulation time (binder addition + massing) is only 20–30% of the total cycle time — the rest is material handling and cleaning.
Run 10 consecutive batches with the same formulation and endpoint detection method. Sample each batch at the endpoint and measure granule size distribution (by sieve analysis or laser diffraction), bulk density, and moisture content. The acceptance criteria: d50 RSD below 15%, bulk density RSD below 8%, moisture content RSD below 10%. If these criteria are met, the endpoint method is validated. If not, the endpoint method requires recalibration or replacement with a more sensitive technology (e.g., torque measurement instead of power consumption).
Aqueous and organic solvent binders can be processed on the same granulator with appropriate cleaning between batches. Organic solvents require explosion-proof construction (ATEX Zone 1 or Zone 22 classification) with sealed motors, grounded components, and nitrogen purge capability — this construction is not standard and must be specified at purchase. Melt granulation requires a heated bowl jacket and temperature-controlled impeller — a standard granulator without heating capability cannot perform melt granulation.
Production-scale high-shear granulators are available up to 1,200 L bowl volume, handling batch sizes up to approximately 500 kg. Above this scale, the energy distribution across the bowl becomes too non-uniform for consistent granule quality, and continuous granulation (using a twin-screw extruder or continuous high-shear mixer) becomes the preferred technology. Continuous granulation also eliminates the scale-up problem entirely — the process is developed at production scale from the outset.
Start with conservative parameters: low impeller speed (50% of maximum), moderate chopper speed (2,000 rpm), slow binder addition rate (2–3% of powder mass per minute), and short massing time (60 seconds). Sample every 30 seconds during massing and assess granule properties by hand (squeeze test — a properly granulated mass forms a cohesive ball that breaks apart under moderate finger pressure). Stop the process when the squeeze test indicates adequate granulation. Use these empirical parameters as the starting point for process optimization, then apply the endpoint detection system for subsequent batches.
Written by David Shi | Chief Industrial Application Engineer
David Shi is a Chief Industrial Application Engineer with 9 years of specialized experience in industrial drying system design, equipment selection, and production process optimization. He focuses on delivering tailored solutions for pharmaceutical, food, and chemical manufacturing, with proven expertise in GMP compliance, ISO 9001 standards, and large-scale production line integration.
Contact Us
Related Information!
Automatic Capsule Filling Machine PriceTablet CompressorDrug Press MachinePharmaceutical EquipmentsMaking CapsulesAutomatic Capsule Filling Machine UKPill capsule fillerAuto Capsule Filling MachineMedicine Manufacturing MachineBlister Pack MachinePress Tablet MachineEmpty Capsule Filling MachineTablet Blister Packing MachineTablet Counting MachineTablet Maker MachineHerbal Tablet Making MachinePharmaceutical Machine ManufacturerRotary tablet pressGel Capsule Filling MachineCapsule MakerSalt Tablet Press MachineTablet Counting Machine UKTablet MakerGel Capsule MachineCapsule Filling Machine AutomaticFluid Bed GranulationSoftgel MachineTablet Press Machine UKEncapsulation Machine PriceAll in Capsule Filling MachineTablet Press AustraliaCapsule Pill MakerPharmaceutical Machine ManufacturersPharmaceutical MachinesSoftgel Encapsulation MachineMilk Tablet PressCapsule Filling Machine South AfricaSize 0 Capsule MachineCapsule FillerCapsule Filling machinesAutomatic Capsule Filling MachineCapsule CounterBlistering Machine in Pharmaceutical IndustryCapsule Machine PriceCapsules Filling Machine